BWA
BIIB icon

Basecamp Wealth Advisors’s Biogen BIIB Stock Holding History

Basecamp Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.1K Buy
144
+41
+40% +$7.84K 0.01% 674
2026
Q1 		$18.9K Hold
103
– – ﹤0.01% 845
2025
Q4 		$18.1K Buy
+103
New +$16.8K ﹤0.01% 819

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Basecamp Wealth Advisors's BIIB Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Biogen (BIIB) stake by 40% in Q2 2026, buying an estimated $7.84K and bringing the position to 144 shares worth $31.1K. The position accounts for 0.01% of the portfolio, ranked #674.

Basecamp Wealth Advisors first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Basecamp Wealth Advisors held 144 shares of Biogen worth $31.1K as of Q2 2026.
  • Basecamp Wealth Advisors bought 41 Biogen shares in Q2 2026, an estimated $7.84K.
  • Biogen made up 0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #674 holding.
  • Basecamp Wealth Advisors first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.